As­traZeneca ex­ec stress­es Calquence's patent life ahead of next Medicare ne­go­ti­a­tions

As­traZeneca says it plans to par­tic­i­pate in the next round of Medicare ne­go­ti­a­tions un­der the In­fla­tion Re­duc­tion Act. But this time around, the com­pa­ny says …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER